Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MSX1 | hg38_v1_chr4_+_4859658_4859672 | 0.38 | 3.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_6588082 Show fit | 5.45 |
ENST00000379953.6
|
lymphocyte antigen 86 |
|
chr1_-_167518583 Show fit | 3.74 |
ENST00000392122.3
|
CD247 molecule |
|
chr1_-_167518521 Show fit | 3.60 |
ENST00000362089.10
|
CD247 molecule |
|
chr13_-_37598750 Show fit | 3.42 |
ENST00000379743.8
ENST00000379742.4 ENST00000379749.8 ENST00000379747.9 ENST00000541179.5 ENST00000541481.5 |
periostin |
|
chr2_-_157488829 Show fit | 3.26 |
ENST00000435117.1
ENST00000439355.5 |
cytohesin 1 interacting protein |
|
chr12_+_9827472 Show fit | 3.19 |
ENST00000617793.4
ENST00000617889.5 ENST00000354855.7 ENST00000279545.7 |
killer cell lectin like receptor F1 |
|
chr1_-_160523204 Show fit | 3.01 |
ENST00000368055.1
ENST00000368057.8 ENST00000368059.7 |
SLAM family member 6 |
|
chr6_-_32816910 Show fit | 2.81 |
ENST00000447394.1
ENST00000438763.7 |
major histocompatibility complex, class II, DO beta |
|
chr11_-_104968533 Show fit | 2.69 |
ENST00000444739.7
|
caspase 4 |
|
chr1_+_110873135 Show fit | 2.60 |
ENST00000271324.6
|
CD53 molecule |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 5.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.5 | 5.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.5 | 4.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 4.5 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.8 | 3.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.7 | 3.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 3.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.9 | 2.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 2.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 7.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 5.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 4.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 3.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 3.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 3.4 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.1 | 2.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 2.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) AIM2 inflammasome complex(GO:0097169) |
0.0 | 2.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 2.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 7.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 5.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 5.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.4 | 3.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 3.4 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 2.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 2.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 2.5 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.1 | 2.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 5.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 5.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 3.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 5.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 5.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 3.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 2.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 2.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 2.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 2.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |